Why do some people have better weight loss results with Ozempic or Wegovy?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership
July 15 (Reuters) - Telehealth company Hims & Hers (HIMS.N), opens new tab is facing a growing number of U.S. investor lawsuits after Novo Nordisk's ( opens new tab decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug through the platform sent shares plunging. A group of shareholders sued Hims on Monday in federal court in San Francisco, accusing its board and senior executives of making false and misleading statements about its financial condition and operations. The case was filed as a so-called derivative lawsuit on behalf of the company. The lawsuit follows two securities class actions filed by Hims investors in the same court last month, seeking damages over the drop in stock price after Novo in late June ended what the companies had initially described as a long-term collaboration designed to make obesity care and treatment more affordable and accessible. Hims, Novo and the lawyers who filed Monday's lawsuit did not immediately respond to requests for comment. Danish drugmaker Novo is not a defendant in the lawsuits. Founded in 2017, San Francisco-based Hims provides health and wellness products focused on weight loss, sexual and mental health and hair loss. Novo on June 23 said it was ending their partnership that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum responded, opens new tab in a post on X that day that accused Novo management of misleading the public and making anticompetitive demands 'that infringe on the independent decision making of providers and limit patient choice.' Hims shares fell $22.24, or over 34%, after Novo's announcement, declining from $64.22 per share on June 20 to close at $41.98 per share on June 23. The stock closed on Monday at $52.03 a share. The tight supply of Wegovy in the United States had allowed Hims and others to sell cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Hims said the decision meant it could not guarantee continued sales of compounded semaglutide. The case is Steve Jones v. Andrew Dudum, U.S. District Court, Northern District of California, No. 3:25-cv-05866-AGT. For plaintiff: Shane Rowley of Rowley Law PLLC, and Francis "Casey" Flynn Jr. of Law Office of Francis J. Flynn Jr For defendants: No appearances yet Read more: Novo, Hims & Hers engage in war of words after Wegovy deal falls apart US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Daily Mail
2 hours ago
- Daily Mail
Kroger issues recall over possibly deadly products in 18 states
Products sold in Kroger stores in more than a dozen states have been recalled due to allergens and deadly bacteria. Health officials have issued two different recall notices this month for baked goods and bacon sold at Kroger, an Ohio-based chain with 2,800 stores nationwide. Earlier this month, Oscar Mayer issued a voluntary recall for its 12-ounce and 36-ounce Turkey Bacon products due to potential contamination with listeria monocytogenes, a bacterium that causes foodborne illness listeria. While most of the 1,600 Americans who fall ill with listeria every year recover on their own, at-risk groups like pregnant women and immunocompromised people may suffer miscarriage, sepsis and seizures. Meanwhile, Lewis Bake Shop Artisan Style Half Loaf bread was recalled a few days later due to the potential presence of undeclared hazelnuts, which could cause severe reactions in the 1.6 million Americans with hazelnut allergies. All recalled products were sold in 18 states: Michigan, Wisconsin, Illinois, Indiana, Ohio, Kentucky, Tennessee, Georgia, Arkansas, Missouri, Alabama, Mississippi, South Carolina, Virginia, North Carolina, West Virginia, Texas and Louisiana. Consumers for both recalls were urged to return products to the place of purchase for a full refund. No illnesses have been reported for either recall. Recalled Oscar Mayer products include 12-ounce packages of Oscar Mayer Turkey Bacon with the product code 71871-54860 and use-by dates of July 19, July 20, July 24, August 1, and August 2, 2025. The recalled 36-ounce packages are labeled with product code 71871-54874 and have use-by dates of July 29 and August 31, 2025. This recall affects Kroger stores in Georgia, South Carolina, Alabama, Ohio, Virginia, Michigan, Indiana, Illinois, Missouri, Kentucky, Tennessee, Arkansas, Mississippi, North Carolina, West Virginia, Texas and Louisiana. These products were found to potentially be contaminated with listeria. Listeria, also called Listeriosis, is a serious infection caused by eating food contaminated with Listeria monocytogenes. It can be found in moist environments, soil, water, decaying vegetation and animals, and can survive refrigeration and other food preservation measures. Many foods can harbor the bug, but it is usually found in unpasteurized milk, soft cheeses and ready-to-eat foods, such as prepacked sandwiches. Cooked shellfish, cured meats and fish, including sushi and pre-cut fruit, are also a risk. Most people who eat food contaminated with listeria will not become seriously ill. But in some cases, it can cause confusion and seizures, miscarriage in pregnant women, and even death. This can happen when the infection spreads beyond the gut and affects the central nervous system, which can lead to numbness and seizures. The CDC estimates 1,600 Americans become infected with listeria every year, and about 260 die. Meanwhile, the Lewis Bake Shop Artisan Style Half Loaf contaminated bread was sold in 12-ounce clear plastic bags with a July 13, 2025, expiration date printed on the front of the packaging and a UPC code 24126018152 printed on the bottom. The six affected lot codes are T10 174010206, T10 174010306, T10 174010406, T10 174020206, T10 174020306 and T10 174020406. All were distributed earlier this month.
Daily Mail
2 hours ago
- Daily Mail
Millions more Americans now deemed obese under shocking new weight measure
Millions more Americans could be classified as obese under a shocking new measurement from Europe. Researchers in Israel analyzed data on 44,000 adults in the US, including nearly 15,000 marked as overweight using existing methods. But under the new framework, they found some 18.8 percent of overweight adults, or one in five, were re-classified as obese. Overall, this translated into America having an obesity rate of 54.2 percent, or a new record. The US already has the highest obesity rate out of any large country. In the new method from Europe, researchers still consider anyone with a Body Mass Index (BMI) over 30 kg/m2 as obese. But they also re-classify anyone who is overweight (a BMI or 25 to 29.9 kg/m2) and has an obesity-related condition, like diabetes or high blood pressure, into the category. Researchers said the new definition reveals the overall toll of obesity in the nation, and the surging number of people already suffering from obesity-related conditions like stroke, heart disease and early death. It also revealed how millions who consider themselves 'just a little overweight' could now be suffering from a weight-related complication. About 42.4 percent of adults in the US are obese, while 30.7 percent, or one in three, are considered overweight. For the study, published in the Annals of Internal Medicine, researchers analyzed data from NHANES, an annual survey tracking participants, including their BMI and underlying conditions. Participants had all submitted data between 1999 and 2018, and were aged 43.4 years old on average. About half were women. The study found that using BMI alone, about 35.4 percent of participants were considered obese, while 33.3 percent were considered overweight and 31.3 percent were considered to be a healthy weight. But after using the new method, developed by The European Association for the Study of Obesity (EASO), a total of 54.2 percent were defined as obese. Of the individuals moved from the overweight to the obese category, they were more likely to be older, with an average age of 51.3 years compared to 36.5 years among those in the overweight category. They were also more likely to be male, and to have at least one underlying condition, with 57.5 percent having one underlying condition like diabetes compared to 34.3 percent in the overweight group. Among the conditions, high blood pressure (79 percent of the group) was most common, followed by arthritis (33.2 percent) and diabetes (15.6 percent). EASO published its new framework in July last year, and some countries, including Ireland and the Netherlands, have already adopted parts of it. The framework recommends surgeons calculate a patient's BMI and then assess underlying health conditions, such as type 2 diabetes or high blood pressure. Under the guidelines, anyone whose BMI is above 30 kg/m2 is automatically classified as obese. But those who are overweight, with a BMI of 25 to 29.9 kg/m2, and have at least one obesity-related health condition are also considered obese. The framework has not been adopted by other major organizations like the World Health Organization, which still recommends using BMI. It can help someone to be defined as obese because it may lead to them being targeted for early interventions to prevent complications like heart disease or stroke. It could also make it easier for them to access medications like Ozempic and help the patient recognize that they may need care. For the study, researchers also analyzed participants for their mortality risk, or risk of death. They found those who were redefined as obese had a similar mortality risk to those who were overweight, but a 50 percent higher risk than those of the healthy weight. In the study, the researchers wrote that the EASO framework may provide a 'more sensitive tool for diagnosing obesity disease earlier'. It added that some people may have experienced unintentional weight loss due to underlying conditions, which may previously have led them to be included in the overweight category.
